Structure-Based Drug Design 2013

At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design conference, you will hear about developments in in silico technology, as well as experimental approaches useful for accurately predicting and modeling the structures of proteins in structure-based drug design efforts. In addition, examples of successful applications of such technology approaches to genome-to-drug lead investigations will be addressed.

Reasons to Attend:

• HEAR about novel ligand-centric approach for force field calculation.

• BE inspired to set up ambitious projects on SBDD using automated analytics pipeline and long-timescale explicit molecular simulation.

• EXAMINE the role of water/solvent in structure-based drug design.

• RE-DISCOVER the potential of fragment-based drug design through simulation of the complete binding process.

• EXPLORE the epigenomic protein landscapes of cancer cells for drug design.

• MEET potential collaborators from both academic and industry practitioners.

Sessions:

• Structure-Based Drug Design for Kinase

• Drug Resistance

• Force Field Calculation

• GPCR

• Water & Solvation in Drug Design

• Fragment-Based Drug Design

• Protein-Protein Interaction

• Epigenetic Targeting